| Company Name: | Olin Corporation | | Ticker Symbol: | OLN | | | WWW Address: | www.olin.com | | CEO: | Joseph D. Rupp | | No. of Employees: | 3,600 | | Common Issue Type: | CS | | Business Description: | The Company engages in the manufacture and sale of chlor alkali products in the United States and internationally.
|
| | | Industry Information: | CHEMICALS - Synthetics [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 17.5 |  0.46 | 17.51 | 17.93 | 17.27 | 17.58 | 17.20 | 1343277 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,373.8 | 78.5 | 1.29 | 2.07 | 0.80 | 8.5 | 4.6 | 19.79 - 8.97 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 17.50 | $ | | PE Ratio - LTM | 8.5 | |
| Market Capitalisation | 1,373.8 | mil |
| Latest Shares Outstanding | 78.5 | mil |
| Earnings pS (EPS) | 2.07 | $ |
| Dividend pS (DPS) | 0.80 | ¢ |
| Dividend Yield | 4.6 | % |
| Dividend Payout Ratio | 39 | % |
| Revenue per Employee | 490,139 | $ |
| Effective Tax Rate | 38.8 | % |
| Float | 78.1 | mil |
| Float as % of Shares Outstanding | 99.5 | % |
| Foreign Sales | 191 | mil |
| Domestic Sales | 1,573 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 8.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 25.6 | % |
| EBITDA Margin | 16.9 | % |
| Pre-Tax Profit Margin | 15.4 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 8.3 | % |
| Return on Equity (ROE) | 19.4 | % |
| Return on Capital Invested (ROCI) | 13.1 | % |
| Current Ratio | 2.6 | |
| Leverage Ratio (Assets/Equity) | 2.3 | |
| Interest Cover | 36.5 | |
| Total Debt/Equity (Gearing Ratio) | 0.48 | |
| LT Debt/Total Capital | 32.0 | % |
| Working Capital pS | 6.77 | $ |
| Cash pS | 4.80 | $ |
| Book-Value pS | 10.58 | $ |
| Tangible Book-Value pS | 6.76 | $ |
| Cash Flow pS | 2.92 | $ |
| Free Cash Flow pS | 0.03 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.65 | |
| Price/Tangible Book Ratio | 2.59 | |
| Price/Cash Flow | 6.0 | |
| Price/Free Cash Flow | 549.5 | |
| P/E as % of Industry Group | 26.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 10/22/2009 |
| Dividend Ex-Date | 11/05/2009 |
| Dividend Record Date | 11/09/2009 |
| Dividend Pay Date | 12/09/2009 |
| Dividend Amount | 200 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.80 |
| Current Dividend Yield | 4.6 |
| 5-Y Average Dividend Yield | 4.2 |
| Payout Ratio | 39.0 |
| 5-Y Average Payout Ratio | 44.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.7 | 101 | 8,791 | 13,458 |
| 4 Weeks | 17.58 | 15.00 | 15.27 | 14.6 | 107 | 10,063 | 161,002 |
| 13 Weeks | 18.40 | 15.00 | 16.79 | 4.2 | 97 | 11,359 | 681,533 |
| 26 Weeks | 18.40 | 10.64 | 13.36 | 31.0 | 109 | 12,982 | 1,609,798 |
| 52 Weeks | 19.79 | 8.97 | 16.38 | 6.8 | 87 | 14,040 | 3,481,874 |
| YTD | 19.79 | 8.97 | - | -3.2 | 79 | 14,334 | 3,239,442 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 17.17 | 16.95 | 16.70 | 14.66 | 14.23 | 1.29 | 1.20 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -6.61 | 18.0 | -16.84 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 35.82 | NA | 40.96 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 15.00 | NA | -2.29 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -11.3 | -21.1 | 38.2 |
| Earnings % | 3.1 | 4.5 | 0.0 |
| EPS % | 0.0 | 2.0 | 0.0 |
| EPS $ | 0.00 | 0.01 | 2.19 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 15.53 |
| Current Ratio | 1.6 |
| Quick Ratio (Acid Test) | 1.1 |
| Liquidity Ratio (Cash) | 0.58 |
| Receivables Turnover | 8.5 |
| Average Collection Period | 42 |
| Working Capital/Equity | 38.4 |
| Working Capital pS | 3.49 |
| Cash-Flow pS | 2.94 |
| Free Cash-Flow pS | -1.26 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.67 |
| Financial Leverage Ratio (Assets/Equity) | 2.5 |
| Debt Ratio | 59.5 |
| Total Debt/Equity (Gearing Ratio) | 0.36 |
| LT Debt/Equity | 0.36 |
| LT Debt/Capital Invested | 64.2 |
| LT Debt/Total Liabilities | 24.3 |
| Interest Cover | 20.4 |
| Interest/Capital Invested | 1.01 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.17 |
| Tobin's Q Ratio | 0.79 |
| Current P/E Ratio - LTM | 8.50 |
| Enterprise Value (EV)/EBITDA | 6.77 |
| Enterprise Value (EV)/Free Cash Flow | -29.60 |
| Dividend Yield | 4.6 |
| Price/Tangible Book Ratio - LTM | 2.59 |
| Price/Book Ratio - LTM | 1.65 |
| Price/Cash Flow Ratio | 6.0 |
| Price/Free Cash Flow Ratio - LTM | 549.5 |
| Price/Sales Ratio | 0.85 |
| P/E Ratio (1 month ago) - LTM | 7.8 |
| P/E Ratio (26 weeks ago) - LTM | 6.2 |
| P/E Ratio (52 weeks ago) - LTM | 9.8 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 26.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 8.5 |
| PER SHARE FIGURES |
| LT Debt pS | 3.26 |
| Current Liabilities pS | 5.45 |
| Tangible Book Value pS - LTM | 6.76 |
| Book Value pS - LTM | 10.58 |
| Capital Invested pS | 12.20 |
| Cash pS - LTM | 4.80 |
| Cash Flow pS - LTM | 2.92 |
| Free Cash Flow pS - LTM | 0.03 |
| Earnings pS (EPS) | 2.07 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -5.54 |
| Free Cash Flow Margin 5YEAR AVG | -6.51 |
| Net Profit Margin | 8.9 |
| Net Profit Margin - 5YEAR AVRG. | 4.7 |
| Equity Productivity | 2.50 |
| Return on Equity (ROE) | 22.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 18.3 |
| Capital Invested Productivity | 1.84 |
| Return on Capital Invested (ROCI) | 16.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 12.4 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | 9.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 5.8 |
| Gross Profit Margin | 25.6 |
| Gross Profit Margin - 5YEAR AVRG. | 18.1 |
| EBITDA Margin - LTM | 16.9 |
| EBIT Margin - LTM | 15.8 |
| Pre-Tax Profit Margin | 14.6 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 8.7 |
| Effective Tax Rate | 38.8 |
| Effective Tax Rate - 5YEAR AVRG. | 34.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 76 |
| Revenue per Employee | 490,139 |
| Net Income per Employee | 43,806 |
| Average Collection Period | 43 |
| Receivables Turnover | 8.5 |
| Day's Inventory Turnover Ratio | 33 |
| Inventory Turnover | 11.0 |
| Inventory/Sales | 7.4 |
| Accounts Payble/Sales | 8.25 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | 6.52 |
| Fixed Assets Turnover | 1.68 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 7.16 |
| Revenue per $ Plant | 2.80 |
| Revenue per $ Common Equity | 2.50 |
| Revenue per $ Capital Invested | 1.84 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 7.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 7.2 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |